| Labatec Pharma SA - Pyrazinamide Labatec 500 mg, comprimés |
| 57699 | | 01 | | Pyrazinamide Labatec 500 mg | | comprimés | | J04AK01 | | Pyrazinamide | | 01.06.2007 | | |
|
| Composition |
| pyrazinamidum 500 mg, carboxymethylamylum natricum A corresp. natrium max. 1.96 mg, cellulosum microcristallinum, copovidonum, calcii stearas, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Pyrazinamide | 500 mg |
| | BAG: Active Agent | Dose |
|---|
| Pyrazinamide | 500 mg |
| | | | Inactive agents |
|---|
| Calcii Stearas | | Carboxymethylamylum Natricum A | | Cellulosum Microcristallinum | | Copovidonum | | Pro Compresso |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 100 Tablet(s) | 66.28 | 88.50 | A | SL | No |
|
